Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-08

Clinical Trial Update: Inhaled Isopropyl Alcohol for Treatment of Nausea [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating inhaled isopropyl alcohol for nausea and vomiting is in Phase 2/3 and currently recruiting, with enrollment limited to children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled isopropyl alcohol (isopropyl alcohol inhalation)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Vomiting, Nausea | Phase 2, Phase 3 | Status: RECRUITING